Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |